APVO 8-K 2026-10-14

Aptevo Therapeutics Inc. (APVO) 8-K dated 2026-10-14 — accession 0001193125-26-421076. This URL is the filing, not the APVO hub.

Aptevo Therapeutics Inc. (APVO) is a biotechnology company listed on US.

Aptevo Therapeutics Inc. filed a 8-K on 2026-10-14. Accession 0001193125-26-421076.

Cached items: 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M.

Not investment advice. The APVO SEC hub lists recent forms. The stock page is the research view.